|
ZNF202 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.390000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.580200E-02 |
| Normal-vs-Stage2 |
1.471150E-01 |
| Normal-vs-Stage3 |
9.658400E-01 |
| Normal-vs-Stage4 |
4.995600E-01 |
| Stage1-vs-Stage2 |
4.703600E-01 |
| Stage1-vs-Stage3 |
2.037600E-01 |
| Stage1-vs-Stage4 |
4.571600E-02 |
| Stage2-vs-Stage3 |
1.514420E-01 |
| Stage2-vs-Stage4 |
7.704000E-02 |
| Stage3-vs-Stage4 |
5.814400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.308000E-02 |
| Normal-vs-AfricanAmerican |
1.817160E-01 |
| Normal-vs-Asian |
4.808400E-01 |
| Caucasian-vs-AfricanAmerican |
5.803600E-01 |
| Caucasian-vs-Asian |
7.468600E-01 |
| AfricanAmerican-vs-Asian |
6.305200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.070100E-02 |
| Normal-vs-Female |
5.583200E-03 |
| Male-vs-Female |
6.098300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.467000E-01 |
| Normal-vs-Extreme_Weight |
1.204770E-01 |
| Normal-vs-Obese |
6.744200E-02 |
| Normal-vs-Extreme_Obese |
7.780400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.749800E-01 |
| Normal_Weight-vs-Obese |
6.127000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.813000E-01 |
| Extreme_Weight-vs-Obese |
6.730400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.442390E-01 |
| Obese-vs-Extreme_Obese |
8.905700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.861640E-02 |
| Normal-vs-Age(41-60Yrs) |
4.896400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.749960E-01 |
| Normal-vs-Age(81-100Yrs) |
3.796600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.720600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.173900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.915720E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.623900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.618100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.515030E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.951900E-04 |
| Normal-VS-Type2 PRCC |
3.873600E-02 |
| Normal-VS-KIRP CIMP |
1.648630E-01 |
| Normal-VS-Unclassified PRCC |
1.524550E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.55802062759858E-12 |
| Type1 PRCC-VS-KIRP CIMP |
9.069800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.590600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.232100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.616400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.033000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.003400E-01 |
| Normal-vs-N1 |
2.249600E-01 |
| Normal-vs-N2 |
2.073600E-01 |
| N0-vs-N1 |
6.418200E-01 |
| N0-vs-N2 |
2.162600E-01 |
| N1-vs-N2 |
1.461380E-01 |
|
|
